GO
Loading...
 
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

Pharma companies navigating 'patent cliffs'

Mon 29 Jul 13 | 08:15 AM ET
Barbara Ryan, FTI Consulting, provides a preview of Pfizer and Merck's earnings, and discusses how both pharma giants have improved shareholder value through M&A.
 
RELATED ARTICLES AND CONTENT
More Videos
Go
Displaying results for: Latest Video | US